Name | Company Name | Weight % | Market Value | Market Cap | Yearly Gain | Overall Rating |
|---|---|---|---|---|---|---|
| Advantest | 3.19% | $4.89M | ¥18.93T | 201.46% | 75 Outperform | |
| HSBC Holdings | 2.85% | $4.37M | £212.73B | 42.42% | 80 Outperform | |
| Novartis AG | 2.24% | $3.43M | CHF238.17B | 31.22% | 80 Outperform | |
| ASML Holding NV | 1.95% | $2.99M | €454.71B | 61.10% | 76 Outperform | |
| Shell (UK) | 1.92% | $2.94M | £162.38B | 7.42% | 73 Outperform | |
| Barclays | 1.77% | $2.71M | £62.63B | 54.11% | 78 Outperform | |
| ABB Ltd | 1.67% | $2.55M | kr1.48T | 36.65% | 78 Outperform | |
| UBS Group AG | 1.63% | $2.49M | $130.32B | 25.16% | 73 Outperform | |
| Banco Bilbao Vizcaya Argentaria | 1.62% | $2.48M | €108.85B | 55.83% | 76 Outperform | |
| Mizuho Financial Group | 1.62% | $2.48M | ¥19.09T | 71.46% | 77 Outperform |